Show simple item record

dc.creatorWilkie, William Scott
dc.date.accessioned2012-06-07T23:19:29Z
dc.date.available2012-06-07T23:19:29Z
dc.date.created2002
dc.date.issued2002
dc.identifier.urihttps://hdl.handle.net/1969.1/ETD-TAMU-2002-THESIS-W347
dc.descriptionDue to the character of the original source materials and the nature of batch digitization, quality control issues may be present in this document. Please report any quality issues you encounter to digital@library.tamu.edu, referencing the URI of the item.en
dc.descriptionIncludes bibliographical references (leaves 51-55).en
dc.descriptionIssued also on microfiche from Lange Micrographics.en
dc.description.abstractThe first objective of this study was to establish the time course of lidocaine and its metabolites, monoethylglycinexylidide (MEGX) and glycinexylidide (GX), in clinically normal dogs. The ultimate goal was to identify the best time(s) for sample collection when disposition of lidocaine is used as a test of hepatic dysfunction. The second goal was to compare the disposition of lidocaine and its metabolites in normal dogs (G1) and dogs with Alport syndrome, a hereditary proteinuric nephritis (G2). Lidocaine (3 mg/kg) was administered intravenously (IV) to six clinically normal dogs. Blood samples were collected intermittently for twelve hours. Concentrations of lidocaine, MEGX, and GX were quantitated in plasma using high performance liquid chromatography (HPLC). The resulting data was subjected to standard non-compartmental analysis. A concentration plateau for MEGX occurred between 10 and 60 minutes and for GX between 60 and 120 minutes after the administration of lidocaine. The ratio of concentrations of GX to MEGX versus time was linear from 15 minutes to 180 minutes after IV administration of lidocaine characterized by a slope of 0.0144± 0.0090 GX/MEGX ratio over time. Subsequently, lidocaine (3 mg/kg) was administered IV to six dogs with Alport syndrome. Pharmacokinetic parameters for lidocaine, MEGX, and GX were compared between groups using Wilcoxon rank sum test. Values for the parameters did not differ between the two groups (p > 0.05). In G2, the concentration plateaus for MEGX and GX occurred at the same time as that found in G1. However, the concentration plateau for MEGX was greater in G2 (193.5 ng/ml) than G1 (143.6 ng/ml). Also, the concentration plateau for GX was greater in G2 (153.7 ng/ml) than G1 (132.6 ng/ml). The ratio between the concentrations of GX and MEGX versus time was linear in G2 from 15 minutes to 180 minutes after IV administration of lidocaine and was characterized by a slope of 0.0211± 0.0119 GX/MEGX ratio over time. The slopes did not differ statistically between G1 and G2.en
dc.format.mediumelectronicen
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherTexas A&M University
dc.rightsThis thesis was part of a retrospective digitization project authorized by the Texas A&M University Libraries in 2008. Copyright remains vested with the author(s). It is the user's responsibility to secure permission from the copyright holder(s) for re-use of the work beyond the provision of Fair Use.en
dc.subjecttoxicology.en
dc.subjectMajor toxicology.en
dc.titlePharmacokinetic disposition of lidocaine and its metabolites following a single intravenous dose in healthy and proteinuric dogsen
dc.typeThesisen
thesis.degree.disciplinetoxicologyen
thesis.degree.nameM.S.en
thesis.degree.levelMastersen
dc.type.genrethesisen
dc.type.materialtexten
dc.format.digitalOriginreformatted digitalen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

This item and its contents are restricted. If this is your thesis or dissertation, you can make it open-access. This will allow all visitors to view the contents of the thesis.

Request Open Access